1. Home
  2. PSNY vs IMCR Comparison

PSNY vs IMCR Comparison

Compare PSNY & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polestar Automotive Holding UK PLC ADS

PSNY

Polestar Automotive Holding UK PLC ADS

HOLD

Current Price

$13.83

Market Cap

2.0B

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$33.95

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSNY
IMCR
Founded
2017
2008
Country
Sweden
United Kingdom
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
PSNY
IMCR
Price
$13.83
$33.95
Analyst Decision
Sell
Buy
Analyst Count
2
10
Target Price
$15.00
$66.33
AVG Volume (30 Days)
124.7K
456.6K
Earning Date
04-17-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.39
EPS
N/A
0.23
Revenue
N/A
$249,428,000.00
Revenue This Year
$31.06
$14.57
Revenue Next Year
$47.98
$8.21
P/E Ratio
N/A
$148.70
Revenue Growth
N/A
43.05
52 Week Low
$0.50
$27.56
52 Week High
$23.75
$40.71

Technical Indicators

Market Signals
Indicator
PSNY
IMCR
Relative Strength Index (RSI) 36.90 54.20
Support Level $12.36 $30.95
Resistance Level $15.01 $35.73
Average True Range (ATR) 0.78 1.32
MACD 0.13 -0.09
Stochastic Oscillator 41.59 53.52

Price Performance

Historical Comparison
PSNY
IMCR

About PSNY Polestar Automotive Holding UK PLC ADS

Polestar Automotive Holding UK PLC is a pure play, premium electric car brand, designing performance cars engineered to excite consumers and drive change. It believes that it defines market standards in design, innovation and sustainability. It is determined to improve society by accelerating the shift to sustainable mobility. The company conducts its business as one operating segment with primary commercial operations in Europe, North America, Asia Pacific and various importer markets. The company generates majority of revenue from United Kingdom.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: